2007～2008年成都地区17家医院生物制品及生化药品利用状况分析

目的：了解2007～2008年成都地区17家医院生物制品及生化药品的使用状况。方法：采用限定日剂量（DDD）的方法,对成都地区2007～2008年17家医院生物制品及生化药品的销售金额、用药频度（DDDs）等进行统计分析。结果：2007年、2008年成都地区17家医院生物制品及生化药品销售总额分别为7338万元、9786万元;分别占总销售额的4.83%、5.00%。销售金额进入总销售额排名前100位的生物制品及生化药品有：人血白蛋白、胸腺肽、丙种球蛋白、促白细胞生长素和环磷腺苷。环磷腺苷在生物制品及生化药品中的DDDs最高。结论：生物制品及生化药品的价格及供给对其临床使用有较大的限制。

Analysis of Biological Products and Biochemical Drugs Utilization in 17 Hospitals of Chengdu Area during 2007 to 2008

Objective：To evaluate the current situation and the trend of biological products and biochemical drugs used in Chengdu city in 2007 to 2008.Methods：Consumption of biological products and biochemical drugs used in 17 hospitals of Chengdu city in 2007 to 2008 were analyzed by the way of sum DDD and DDDs ranking.Results：The total cost of the biological products and biochemical drugs used in Chengdu city in was 73.38 and 97.86 million yuan in 2007 to 2008,it accounted for 4.83%and 5.00%of the total cost.Human serum albumin,thymosin,gamma globulin,interleukin promoting growth hormone and adenosine cyclophosphate were the drugs in the first 100 cost list.The DDDs of adenosine cyclophosphate was highest among biological products and biochemical drugs.Conclusion：The cost and supply of biological products and biochemical drugs were great limitations of their clinical application.